We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Mass Spectrometry Technique Allows Monitoring of Individual Proteins

By LabMedica International staff writers
Posted on 19 Jan 2011
A novel technique allows researchers to follow changes that occur in proteins during periods of stress or during development of a disease.

Investigators at the Scripps Research Institute (Jupiter, FL, USA) exploited the properties of two chemical compounds, dimedone and iododimedone, to trace modification of proteins at the site of cysteine amino acid residues. More...


They reported in the January 5, 2011, online edition of the journal Angewandte Chemie that analysis by mass spectrometry allowed detection of the interaction between the reagents and cysteine residues that had been modified by the process of S-hydroxylation. S-hydroxylation, which occurs when situations of stress trigger the release of reactive oxidative molecules, converts cysteine into a sulfenic acid. It is this acid that reacts with dimedone and iododimedone.

The mass spectrometry method was so sensitive that in addition to quantifying modifications to different proteins, it was able to monitor changes that occurred at the level of individual cysteines within a single protein.

"Chronic disease states such as cancer can involve the modification of signaling proteins through S-hydroxylation, but other housekeeping proteins may also be targets," said senior author Dr. Kate Carroll, associate professor of chemistry at the Scripps Research Institute. "This new technique allows us to home in on which proteins are modified to a significant extent during periods of stress and how that changes during disease progression. It gives us the chance to look more closely at targets for possible therapeutic intervention. From a practical standpoint, the technique is simple and will be accessible to biologists and chemists alike."

"Key to distinguishing which of these proteins may be involved in pathogenesis is the ability to measure the amount of S-hydroxylation at specific sites within a protein,” said Dr. Carroll. "Now you will be able to tell. This should help accelerate target identification in these disease-related signaling pathways and allow us to focus on proteins that are important to the process."

Related Links:
Scripps Research Institute



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hematology Consumables
Bioblood Devices
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.